At GAIKER, we specialize in the selection of specific markers and the selection of biological recognition molecules, primarily antibodies and nucleic acids (including aptamers). These molecules are crucial for detecting markers of interest to our customers and collaborators. Our process involves rigorous candidate screening and rejection strategies to identify those exhibiting optimal properties in terms of selectivity, specificity, precision and repeatability. Once candidates are selected, we are able to undertake more advanced stages of biodetection test development, including conjugation, immobilisation and other customised modifications.
Subscribe to our newsletter